The html and pdf versions of this paper have been corrected. The printed version of the paper also carries the correct information.
In page 1, the reference number '19' in the line: 'In the context of transplantation, we have previously shown that over expression of IDO induces a protective effect against rejection of allergenic grafts by inhibiting alloreactive T-cell activities. 17, 19 ' has been deleted. In page 6, the reference number '16, 18' in the line: 'Because we have previously demonstrated that IDO plays a role in allograft tolerance, 16, 18 we tested whether IDO is essential for the protection of skin allografts by infusion of donor-derived SSCs.' has been changed to '17, 19'. Figure 7a in the above paper appeared incorrectly. One asterisk in the graph in Figure 7a is missing. The correct graph, which is shown as below, has been used to replace the incorrect one.
The content of reference 24 has been changed to: Munn DH, Sharma MD, Hou D, Baban B, Lee JR, Antonia SJ et al. The editorial office would like to apologize for the mistakes. Figure 7 Intravenous infusion of SSC-derived DCs prolongs the survival of heart allografts and attenuates the infiltrate of leukocytes into the grafts. (a) C57BL/6 mouse recipients were treated with intravenous infusion of either 2310 5 SSCderived DCs from BALB/c mice per mouse or PBS 7 days prior to transplantation. Subsequently, the mice were transplanted with BALB/c heart grafts (n56-8 mice per group). The MST of the grafts was monitored. **P,0.01. (b) Histological analysis of heart allografts after transplantation revealed a reduced level of allograft leukocytes infiltration and necrosis in the SSC-derived DC-treated group compared to that in the PBS-treated group (3200). The data shown are representative of three independent experiments. DC, dendritic cell; MST, mean survival time; PBS, phosphate-buffered saline; SSC, splenic stromal cell. 
